<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00498706</url>
  </required_header>
  <id_info>
    <org_study_id>R01MH059708</org_study_id>
    <secondary_id>R01MH059708</secondary_id>
    <nct_id>NCT00498706</nct_id>
  </id_info>
  <brief_title>Effectiveness of Telephone Versus Face-to-Face CBT in Treating People With Depression</brief_title>
  <official_title>Telephone Versus Face-to-Face Administration of CBT for Depression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Mental Health (NIMH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Northwestern University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will compare the effectiveness of telephone versus face-to-face administration of
      cognitive behavioral therapy in treating people with depression.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Major depressive disorder is a common and often long-lasting disorder with 12-month
      prevalence rates estimated to be between 6.6% and 10.3%. Although the personal and societal
      costs of depression are high, it is well established that depression can be effectively
      treated using antidepressant medication and/or forms of psychotherapy. Several studies have
      found that when given a choice, about two-thirds of depressed patients prefer psychotherapy
      or counseling over antidepressant medication. However, a variety of barriers exist to
      initiating and maintaining psychotherapy. Only about 20% of all patients referred for
      psychotherapy actually initiate treatment, and of those who do initiate treatment, nearly
      half drop out before completing treatment. The use of the telephone to deliver treatment
      services has been recommended as a way to reduce many of the barriers associated with failure
      to initiate and sustain treatment. When administered over the telephone, cognitive behavioral
      therapy (CBT), a form of psychotherapy that teaches ways to modify thoughts and behaviors
      that contribute to depression, may be superior to face-to-face CBT in improving treatment
      adherence and reducing depressive symptoms. This study will compare the effectiveness of
      telephone CBT (T-CBT) versus face-to-face CBT (FtF-CBT) in treating people with depression.

      Participation in this study will include 18 weeks of treatment and 12 months of follow-up.
      All participants will first undergo baseline assessments that will include a telephone
      interview and questionnaires about mood. Participants will then be assigned randomly to
      receive T-CBT or FtF-CBT. Participants in both groups will receive eighteen 45-minute
      sessions of their assigned treatment over 18 weeks. Sessions will occur twice a week for 2
      weeks, once a week for 12 weeks, and once every 2 weeks for the last 4 weeks. During
      sessions, participants will learn ways to modify thoughts and behaviors that contribute to
      their depression and ways to maintain the lifestyle changes that they have made. Treatment
      sessions will be identical for both groups, except one group will receive sessions over the
      telephone and the other in-person at a study office. All participants will repeat the
      baseline assessments at Weeks 4, 9, 14, and 18 of treatment and Months 3, 6, 9, and 12 of
      follow-up.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2007</start_date>
  <completion_date type="Actual">May 2012</completion_date>
  <primary_completion_date type="Actual">May 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Attrition (Number of Therapy Sessions Attended)</measure>
    <time_frame>Post treatment, up to 18 weeks</time_frame>
    <description>Number of therapy sessions attended was collected. At the end of treatment, the total number of sessions attended by each patient was collected.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants Who Dropped Out of Therapy</measure>
    <time_frame>Post treatment, up to 18 weeks</time_frame>
    <description>Using the number of therapy sessions attended, we categorized patients into:
those who discontinued treatment before session 18, and those who completed session 18.
those who discontinued before Session 5, and those who continued.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient Health Questionnaire (PHQ)-9</measure>
    <time_frame>Measured at baseline; Weeks 4, 9, 14, and 18; and Months 3, 6 post-treatment follow-up</time_frame>
    <description>Measures depression on a 9 - item scale. Scores range from 0-27, with 0 being no symptoms. A difference of 5 or more points on the PHQ-9 is considered a clinically meaningful response to treatment.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Depression, as Assessed by Hamilton Depression Rating Scale(Ham-D)</measure>
    <time_frame>Measured at baseline; Weeks 4, 9, 14, and 18; and Months 3, 6, 9, and 12 of follow-up</time_frame>
    <description>Ham-D indicates Hamilton Depression Rating Scale,range is 0 to 52. A score of 0 means the best outcome with no depression symptoms reported, and a score of 52 is the worse outcome with highest level of depression reported. A difference of 3 points on the Hamilton scale has been identified as clinically significant.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Health-related Quality of Life (SF-36V), Patient Satisfaction (Satisfaction Index - Mental Health), and Therapeutic Alliance (Working Alliance Inventory - Short Form)</measure>
    <time_frame>Measured at baseline; Weeks 4, 9, 14, and 18; and Months 3, 6, 9, and 12 of follow-up</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">325</enrollment>
  <condition>Depression</condition>
  <arm_group>
    <arm_group_label>Telephone-administered CBT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive telephone-administered cognitive behavioral therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Face-to-face CBT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will receive face-to-face cognitive behavioral therapy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Telephone-administered cognitive behavioral therapy (T-CBT)</intervention_name>
    <description>Over 18 weeks, participants will receive eighteen 45-minute sessions of T-CBT administered by a therapist. Participants will undergo telephone-administered sessions twice a week for 2 weeks, once a week for 12 weeks, and once every 2 weeks for the last 4 weeks. Participants will be taught ways to modify thoughts and behaviors that contribute to their depression and ways to maintain the lifestyle changes that they have made.</description>
    <arm_group_label>Telephone-administered CBT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Face-to-face administered CBT (FtF-CBT)</intervention_name>
    <description>Over 18 weeks, participants will receive eighteen 45-minute sessions of FtF-CBT administered by a therapist. Participants will undergo face-to-face administered sessions twice a week for 2 weeks, once a week for 12 weeks, and once every 2 weeks for the last 4 weeks. Participants will be taught ways to modify thoughts and behaviors that contribute to their depression and ways to maintain the lifestyle changes that they have made.</description>
    <arm_group_label>Face-to-face CBT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Has a current diagnosis of major depressive disorder

          -  Has a primary care physician at Northwestern University in Illinois, or one of a
             number of approved community clinics in Chicago.

          -  Resides in Illinois

          -  Has a telephone

          -  Speaks and reads English

        Exclusion Criteria:

          -  Hearing, voice, or visual impairment

          -  Meets criteria for dementia

          -  Diagnosed with a psychotic disorder, bipolar disorder, dissociative disorder, current
             substance abuse, or other condition for which participation in a clinical trial of
             psychotherapy may be either inappropriate or dangerous

          -  Currently receiving individual psychotherapy or planning to receive psychotherapy
             during the treatment phase of the study

          -  Planning to be out of town or unavailable for treatment for 4 weeks or more during the
             scheduled treatment time

          -  Recent history of suicide attempts or is severely suicidal

          -  Initiated treatment with an antidepressant in the 2 months before study entry
             (antidepressant medication is not exclusionary)

          -  Depression determined to be primarily of an organic etiology
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David C. Mohr, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwestern University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 8, 2007</study_first_submitted>
  <study_first_submitted_qc>July 9, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 10, 2007</study_first_posted>
  <results_first_submitted>August 20, 2012</results_first_submitted>
  <results_first_submitted_qc>July 15, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 17, 2013</results_first_posted>
  <last_update_submitted>July 15, 2013</last_update_submitted>
  <last_update_submitted_qc>July 15, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 17, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Institute of Mental Health (NIMH)</investigator_affiliation>
    <investigator_full_name>David Mohr</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Depressive Disorder, Major</keyword>
  <keyword>Cognitive Behavioral Therapy</keyword>
  <keyword>Psychotherapy</keyword>
  <keyword>Telemedicine</keyword>
  <keyword>Primary Care</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were recruited from November 2007 to December 2010 from general internal medicine clinics in Northwestern Medical Faculty Foundation and Northwestern Memorial Physician’s Group, and from 4 primary care clinic members of Northwestern’s Practice-Based Research Network.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Telephone-administered CBT</title>
          <description>Participants will receive telephone-administered cognitive behavioral therapy.</description>
        </group>
        <group group_id="P2">
          <title>Face-to-face CBT</title>
          <description>Participants will receive face-to-face cognitive behavioral therapy.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="163"/>
                <participants group_id="P2" count="162"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Post Treatment Week 18</title>
              <participants_list>
                <participants group_id="P1" count="163"/>
                <participants group_id="P2" count="162"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="163"/>
                <participants group_id="P2" count="162"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Telephone-administered CBT</title>
          <description>Participants will receive telephone-administered cognitive behavioral therapy.</description>
        </group>
        <group group_id="B2">
          <title>Face-to-face CBT</title>
          <description>Participants will receive face-to-face cognitive behavioral therapy.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="163"/>
            <count group_id="B2" value="162"/>
            <count group_id="B3" value="325"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="150"/>
                    <measurement group_id="B2" value="148"/>
                    <measurement group_id="B3" value="298"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="47.8" spread="12.6"/>
                    <measurement group_id="B2" value="47.5" spread="13.5"/>
                    <measurement group_id="B3" value="47.6" spread="13.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="125"/>
                    <measurement group_id="B2" value="127"/>
                    <measurement group_id="B3" value="252"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                    <measurement group_id="B2" value="35"/>
                    <measurement group_id="B3" value="73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="163"/>
                    <measurement group_id="B2" value="162"/>
                    <measurement group_id="B3" value="325"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Attrition (Number of Therapy Sessions Attended)</title>
        <description>Number of therapy sessions attended was collected. At the end of treatment, the total number of sessions attended by each patient was collected.</description>
        <time_frame>Post treatment, up to 18 weeks</time_frame>
        <population>A randomized controlled trial of 325 Chicago area primary care patients with major depressive disorder, recruited from November 1007 to December 2010.</population>
        <group_list>
          <group group_id="O1">
            <title>Telephone-administered CBT</title>
            <description>Participants will receive telephone-administered cognitive behavioral therapy.</description>
          </group>
          <group group_id="O2">
            <title>Face-to-face CBT</title>
            <description>Participants will receive face-to-face cognitive behavioral therapy.</description>
          </group>
        </group_list>
        <measure>
          <title>Attrition (Number of Therapy Sessions Attended)</title>
          <description>Number of therapy sessions attended was collected. At the end of treatment, the total number of sessions attended by each patient was collected.</description>
          <population>A randomized controlled trial of 325 Chicago area primary care patients with major depressive disorder, recruited from November 1007 to December 2010.</population>
          <units>Number of Sessions</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="163"/>
                <count group_id="O2" value="162"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>sessions</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2518"/>
                <count group_id="O2" value="2221"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.4" spread="4.4"/>
                    <measurement group_id="O2" value="13.7" spread="6.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.003</p_value>
            <method>t-test, 2 sided</method>
            <param_type>t value</param_type>
            <param_value>-2.95</param_value>
            <ci_percent>95</ci_percent>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Who Dropped Out of Therapy</title>
        <description>Using the number of therapy sessions attended, we categorized patients into:
those who discontinued treatment before session 18, and those who completed session 18.
those who discontinued before Session 5, and those who continued.</description>
        <time_frame>Post treatment, up to 18 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Telephone-administered Cognitive Behavioral Therapy</title>
            <description>Participants will receive telephone-administered cognitive behavioral therapy.</description>
          </group>
          <group group_id="O2">
            <title>Face-to-face Cognitive Behavioral Therapy</title>
            <description>Participants will receive face-to-face cognitive behavioral therapy.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Dropped Out of Therapy</title>
          <description>Using the number of therapy sessions attended, we categorized patients into:
those who discontinued treatment before session 18, and those who completed session 18.
those who discontinued before Session 5, and those who continued.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="163"/>
                <count group_id="O2" value="162"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>those who discontinued treatment before session 18</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                    <measurement group_id="O2" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>those who discontinued before Session 5,</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.02</p_value>
            <method>Chi-squared</method>
            <param_type>Chi-square</param_type>
            <param_value>5.83</param_value>
            <ci_percent>95</ci_percent>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.006</p_value>
            <method>Chi-squared</method>
            <param_type>Chi-square</param_type>
            <param_value>7.75</param_value>
            <ci_percent>95</ci_percent>
            <estimate_desc>Attrition before week 5 was significantly lower in T-CBT than in face-to-face CBT.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Health-related Quality of Life (SF-36V), Patient Satisfaction (Satisfaction Index - Mental Health), and Therapeutic Alliance (Working Alliance Inventory - Short Form)</title>
        <time_frame>Measured at baseline; Weeks 4, 9, 14, and 18; and Months 3, 6, 9, and 12 of follow-up</time_frame>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Patient Health Questionnaire (PHQ)-9</title>
        <description>Measures depression on a 9 - item scale. Scores range from 0-27, with 0 being no symptoms. A difference of 5 or more points on the PHQ-9 is considered a clinically meaningful response to treatment.</description>
        <time_frame>Measured at baseline; Weeks 4, 9, 14, and 18; and Months 3, 6 post-treatment follow-up</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Telephone-administered CBT</title>
            <description>Participants will receive telephone-administered cognitive behavioral therapy.</description>
          </group>
          <group group_id="O2">
            <title>Face-to-face CBT</title>
            <description>Participants will receive face-to-face cognitive behavioral therapy.</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Health Questionnaire (PHQ)-9</title>
          <description>Measures depression on a 9 - item scale. Scores range from 0-27, with 0 being no symptoms. A difference of 5 or more points on the PHQ-9 is considered a clinically meaningful response to treatment.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="162"/>
                <count group_id="O2" value="163"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.76" spread="4.7" lower_limit="16.24" upper_limit="17.29"/>
                    <measurement group_id="O2" value="16.76" spread="4.8" lower_limit="16.24" upper_limit="17.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week04</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.78" lower_limit="9.92" upper_limit="11.64"/>
                    <measurement group_id="O2" value="10.09" lower_limit="9.21" upper_limit="10.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week09</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.05" lower_limit="8.13" upper_limit="9.96"/>
                    <measurement group_id="O2" value="8.62" lower_limit="7.64" upper_limit="9.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week14</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.55" lower_limit="7.53" upper_limit="9.56"/>
                    <measurement group_id="O2" value="7.77" lower_limit="6.73" upper_limit="8.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week18</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.65" lower_limit="5.72" upper_limit="7.58"/>
                    <measurement group_id="O2" value="6.74" lower_limit="5.74" upper_limit="7.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3-month follow-up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.59" lower_limit="6.60" upper_limit="8.58"/>
                    <measurement group_id="O2" value="6.60" lower_limit="5.56" upper_limit="7.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-month follow-up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.42" lower_limit="7.38" upper_limit="9.46"/>
                    <measurement group_id="O2" value="6.30" lower_limit="5.24" upper_limit="7.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Longitudinal depression scores were modeled with repeated-measures linear regression models.Time was treated as a categorical variable to account for nonlinear effects of time, and an unstructured covariance matrix was assumed.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Noninferiority is established by showing that the true difference between 2 treatment arms is likely to be smaller than a prespecified noninferiority margin that separates clinically important from clinically negligible (acceptable) differences.</non_inferiority_desc>
            <p_value>0.89</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-0.09</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>1.26</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.35</ci_lower_limit>
            <ci_upper_limit>1.17</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Depression, as Assessed by Hamilton Depression Rating Scale(Ham-D)</title>
        <description>Ham-D indicates Hamilton Depression Rating Scale,range is 0 to 52. A score of 0 means the best outcome with no depression symptoms reported, and a score of 52 is the worse outcome with highest level of depression reported. A difference of 3 points on the Hamilton scale has been identified as clinically significant.</description>
        <time_frame>Measured at baseline; Weeks 4, 9, 14, and 18; and Months 3, 6, 9, and 12 of follow-up</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Telephone-administered CBT</title>
            <description>Participants will receive telephone-administered cognitive behavioral therapy.</description>
          </group>
          <group group_id="O2">
            <title>Face-to-face CBT</title>
            <description>Participants will receive face-to-face cognitive behavioral therapy.</description>
          </group>
        </group_list>
        <measure>
          <title>Depression, as Assessed by Hamilton Depression Rating Scale(Ham-D)</title>
          <description>Ham-D indicates Hamilton Depression Rating Scale,range is 0 to 52. A score of 0 means the best outcome with no depression symptoms reported, and a score of 52 is the worse outcome with highest level of depression reported. A difference of 3 points on the Hamilton scale has been identified as clinically significant.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="163"/>
                <count group_id="O2" value="162"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.83" spread="4.6" lower_limit="22.34" upper_limit="23.33"/>
                    <measurement group_id="O2" value="22.83" spread="4.6" lower_limit="22.34" upper_limit="23.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week04</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.07" lower_limit="17.16" upper_limit="18.98"/>
                    <measurement group_id="O2" value="17.86" lower_limit="16.96" upper_limit="18.77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week09</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.62" lower_limit="14.60" upper_limit="16.65"/>
                    <measurement group_id="O2" value="16.45" lower_limit="15.40" upper_limit="17.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week14</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.94" lower_limit="13.77" upper_limit="16.12"/>
                    <measurement group_id="O2" value="14.18" lower_limit="12.97" upper_limit="15.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week18</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.58" lower_limit="12.42" upper_limit="14.74"/>
                    <measurement group_id="O2" value="12.51" lower_limit="11.22" upper_limit="13.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3-month follow-up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.58" lower_limit="13.45" upper_limit="15.71"/>
                    <measurement group_id="O2" value="12.33" lower_limit="11.1" upper_limit="13.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-month follow-up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.06" lower_limit="13.84" upper_limit="16.27"/>
                    <measurement group_id="O2" value="12.14" lower_limit="10.84" upper_limit="13.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Longitudinal depression scores were modeled with repeated-measures linear regression models.Time was treated as a categorical variable to account for nonlinear effects of time, and an unstructured covariance matrix was assumed.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Noninferiority is established by showing that the true difference between 2 treatment arms is likely to be smaller than a prespecified noninferiority margin that separates clinically important from clinically negligible (acceptable) differences.</non_inferiority_desc>
            <p_value>0.22</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>1.07</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>1.695</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.63</ci_lower_limit>
            <ci_upper_limit>2.76</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Telephone-administered CBT</title>
          <description>Participants will receive telephone-administered cognitive behavioral therapy.</description>
        </group>
        <group group_id="E2">
          <title>Face-to-face CBT</title>
          <description>Participants will receive face-to-face cognitive behavioral therapy.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="163"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="162"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="163"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="162"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. David C. Mohr</name_or_title>
      <organization>Northwestern University</organization>
      <phone>312-503-1403</phone>
      <email>d-mohr@northwestern.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

